Correlations between self-reported and psychiatrist assessments of well-being among patients with schizophrenia

Aunjitsakul, Warut; Teetharatkul, Teerapat; Vitayanont, Arnont; Liabsuetrakul, Tippawan

doi:10.1016/j.genhosppsych.2018.11.001

Cited by 4 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A pre-test of the translated questionnaires assessing their practical usage and understanding was performed. The SWN Thai version showed good inter-rater reliability with Kappa of 0.88 (SD 0.24) [ 12 ].…”

Section: Methodsmentioning

confidence: 99%

“…Several studies have focused on investigating the symptom severity associated with patients’ well-being in schizophrenia, [ 12 – 16 ] but evidence from low- and middle-income countries, like Thailand, is still limited. We hoped that the use of additional tools rather than physician’s assessment alone could help assess symptom severity by identifying a specific symptom that the physician should focus on for targeted treatment in improvement of patients’ well-being.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Severity of symptoms in patients with schizophrenia is a determinant of patient’s well-being, but evidence in low- and middle-income countries is limited. We aimed to measure the symptom severity using objective measurements, the Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression-Severity scale (CGI-S), and their associations with well-being in patients with schizophrenia. Methods Patients with schizophrenia aged ≥18 years, without active psychosis including no history of hospitalization within the last 6 months, were included. Symptom severity was measured by the clinicians using BPRS and CGI-S. The patients’ well-being was assessed by self-report using the Subjective Well-being under Neuroleptic treatment scale (SWN) as continuous and binary outcomes (categorized into adequate or poor well-being). Correlations between symptom severity (BPRS and CGI-S scores) and well-being (SWN score) were analyzed using Pearson’s correlation. Association between well-being status and BPRS was analyzed using multivariate logistic regression. Results Of 150 patients, BPRS and CGI-S were inversely correlated with SWN score (r = − 0.47; p < 0.001 and − 0.21; p < 0.01, respectively). BPRS Affect domain had the highest correlation with SWN (r = − 0.51, p < 0.001). In multivariate logistic regression, BPRS score and being unemployed were associated with poor well-being status (adjusted OR 1.08; 95%CI 1.02–1.14; p = 0.006, and 4.01; 95%CI 1.38–11.7; p = 0.011, respectively). Conclusion Inverse relationships between symptom severity and well-being score were found. Higher BPRS Affect domain was significantly associated with lower patients’ well-being. The use of BPRS tool into routine clinical practice could serve as an adjunct to physician’s clinical evaluation of patients’ symptoms and may help improve patient’s well-being. Further research on negative symptoms associated with well-being is required.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…The rate of LAIs usage among schizophrenia at the psychiatry department of the Faculty of Medicine, Prince of Songkla University, in 2018, was 12.7%. 13 The reason for this low prescribing rate of LAIs may be the patient attitudes and reluctance to accept depot treatment. 10 Despite good clinical evidence, depot treatment rates are still low across countries, 7 and depot antipsychotics are only seldom prescribed for patients with FES.…”

Section: Introductionmentioning

confidence: 99%

Attitudes Toward Long-Acting Injectable Antipsychotics among Schizophrenia Patients in Southern Thailand: A Multihospital-Based Cross- Sectional Survey

Pitanupong

Karakate

Tepsuan³

et al. 2022

Siriraj Med J

View full text Add to dashboard Cite

Objective: To identify the attitudes toward long-acting injectable antipsychotics (LAIs) among schizophrenia atthree psychiatric outpatient clinics in Southern Thailand from February to April 2021.Materials and Methods: A study was conducted at three psychiatric outpatient clinics. All patients, who met the criteria of having schizophrenia based on ICD-10 criteria, aged 20-60 years were included. The questionnaires utilized were:1) Demographic information, 2) Profile of schizophrenia disorder, and 3) Attitude, knowledge, and satisfaction towards LAIs. All data were analyzed using descriptive statistics.Results: There were 259 participants who completed the questionnaires. From the participants, 39% had a history of being treated with LAIs. A quarter of them felt LAIs made them feel stigmatized (26.3%), that they lost autonomy (24.7%), and embarrassed (16.6%). The reasons for refusing to receive LAIs were not fear of needles or pain at the injection site (49%), but rather that LAIs had more adverse effects than oral medications (47.9%). Half of them (51.8%) knew that they must continue to use LAIs, even though their symptoms had improved as LAIs played an important role by improving their symptoms (68.8%), and preventing relapse (51.8%). They were satisfied about having been involved in the decision making of using LAIs for their treatment (63.6%), having information on therisk-benefits from LAIs provided to them (72.3%), and the cost of LAIs (75.2%).Conclusion: Before deciding to prescribe LAIs, we should ensure that all patients receive information about the risks, and benefits of LAIs, boosting acceptance for this formulation and mitigating concerns about patient autonomy reduction and stigmatization.

show abstract

Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?

Aunjitsakul

Teetharatkul

Vitayanont

et al. 2021

Adm Policy Ment Health

View full text Add to dashboard Cite

Correlations between self-reported and psychiatrist assessments of well-being among patients with schizophrenia

Cited by 4 publications

References 8 publications

Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study

Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study

Attitudes Toward Long-Acting Injectable Antipsychotics among Schizophrenia Patients in Southern Thailand: A Multihospital-Based Cross- Sectional Survey

Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?

Contact Info

Product

Resources

About